Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Gates Foundation

Global: To Leverage Mutational Antigenic Profiling to Advance the Design of Vaccines and Therapeutics to SARS-CoV-2, Influenza Virus and HIV

Last update: 1 day ago Last update: Dec 19, 2025

Details

Locations:USA
Start Date:Oct, 2020
End Date:Mar, 2026
Contract value: USD 899,997
Sectors:Health
 Health
Categories:Grants
Funding Agencies:
Gates Foundation
Date posted:Dec 19, 2025

Associated funding

Associated experts

Description

Purpose: To leverage mutational antigenic profiling to advance the design of vaccines and therapeutics to SARS-CoV-2, influenza virus and HIV
Division: Global Health
Region served: GLOBAL
Grant topic: Discovery and Translational Sciences, HIV
Duration (months): 65
Grantee location: Seattle, Washington, United States

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print